ReleVote

Second Chance for Moms Act

Bill Number
H.R. 796
Origin Chamber
House
Congress
119th Congress, Session 1
Policy Area
Health
Status
Introduced
Latest Action
2025-01-28: Referred to the House Committee on Energy and Commerce.
Last Updated
2025-07-28T15:24:41Z

Official Summary

Second Chance for Moms Act of 2025

This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

Sponsor

Rep. Miller, Mary E. [R-IL-15]

Cosponsors (13)

Rep. Babin, Brian [R-TX-36], Rep. Moore, Barry [R-AL-1], Rep. Moore, Riley [R-WV-2], Rep. Ogles, Andrew [R-TN-5], Rep. Webster, Daniel [R-FL-11], Rep. Tenney, Claudia [R-NY-24], Rep. Clyde, Andrew S. [R-GA-9], Rep. Harris, Andy [R-MD-1], Rep. Weber, Randy K. Sr. [R-TX-14], Rep. Harris, Mark [R-NC-8], Rep. Palmer, Gary J. [R-AL-6], Rep. Rose, John W. [R-TN-6], Rep. Biggs, Sheri [R-SC-3]

Recent Actions

Bill Versions